ratio did not exceed 3.00 times, which is the covenant for bank loans and debentures. 3 Income Statement For the year ended December 31 Change Unit: Million Baht 2019 2018 Amount % Revenues from
% Change Amount % Amount % Amount % Q1-20 VS Q1-19 Q1-20 VS Q4-19 Sales revenue 12,680 100.0 12,949 100.0 11,707 100 (2.1) 8.3 Gross profit 2,586 20.4 2,978 23.0 2,155 18.4 (13.2) 20.0 Operating profit 549
of the plant and machineries from an independent engineering expert. The effect of such change in the estimated useful lives of assets to the depreciation charge during the quarter is as below; Unit
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
% 2.2% 29.9% 27.2% (2.7%) Net profit margin1 (%) 17.7% 8.1% (9.6%) 19.7% 7.1% (12.6%) Number of branches as at Dec 312 38 39 3% 38 39 3% 2019 2020 Change +/(-) Change +/(-) Q4/19 Q4/20 Operating highlight
dream? Project could https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=5400 Climate change is everybody’s business and capital market could drive the change needed responsible business behavior and
baht, Start a journey to your dream? Project could https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=5400 Climate change is everybody’s business and capital market could drive the change needed
Discussion & Analysis Q2/2022 Operating Highlights in Q4/2021 Q2/21 Q2/22 Change +/(-) 1H/21 1H/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 137 230 68% 317 428 35% Gross Profit 77 147 91% 183 267
Discussion & Analysis Q3/2022 Operating Highlights in Q3/2022 Q3/21 Q3/22 Change +/(-) 9M/21 9M/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 115 246 114% 431 674 56% Gross Profit 60 159 165% 242